syndrome	score	normalized_score
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.000541419	100.0
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.20411284899999999	20.40023982255551
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.200541419	20.043290081927132
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.2	19.98917747951822
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.2	19.98917747951822
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	19.98917747951822
VICI SYNDROME; VICIS	0.167208419	16.71179381730323
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.167208419	16.71179381730323
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.166667	16.657681214894314
SCHIZENCEPHALY	0.166667	16.657681214894314
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.156139849	15.605535766430876
PITUITARY STALK INTERRUPTION SYNDROME	0.15256841899999998	15.248586025802496
PITUITARY CARCINOMA	0.13813799999999998	13.806324993328436
CULLER-JONES SYNDROME; CJS	0.13813799999999998	13.806324993328436
FRONTORHINY	0.13813799999999998	13.806324993328436
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.129112849	12.90429826773618
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.12857143	12.850185665327263
CENTRAL CONGENITAL HYPOTHYROIDISM	0.12857143	12.850185665327263
RHOMBENCEPHALOSYNAPSIS	0.125	12.493235924698887
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.125	12.493235924698887
CRANIOTELENCEPHALIC DYSPLASIA	0.125	12.493235924698887
ACROMELIC FRONTONASAL DYSPLASIA	0.11165241899999999	11.159200097042659
ISOLATED BILIARY ATRESIA	0.11165241899999999	11.159200097042659
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.11165241899999999	11.159200097042659
HYPERTRIGLYCERIDEMIA, FAMILIAL	0.11111099999999999	11.105087494633741
HYPERLIPOPROTEINEMIA, TYPE IV	0.11111099999999999	11.105087494633741
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.11111099999999999	11.105087494633741
EXUDATIVE VITREORETINOPATHY 3; EVR3	0.11111099999999999	11.105087494633741
RHYNS SYNDROME	0.11111099999999999	11.105087494633741
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.11111099999999999	11.105087494633741
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.11111099999999999	11.105087494633741
EXUDATIVE VITREORETINOPATHY 5; EVR5	0.11111099999999999	11.105087494633741
EXUDATIVE VITREORETINOPATHY 4	0.11111099999999999	11.105087494633741
HOLOPROSENCEPHALY	0.08669544900000001	8.664853583637603
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.0825826	8.253791240600307
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.07031233	7.027428216842267
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.06674089999999999	6.670478476213887
MICROFORM HOLOPROSENCEPHALY	0.06450037900000001	6.44654761663595
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.0615098	6.147651544648348
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.05928509999999999	5.925301928954927
SHEEHAN SYNDROME	0.059127030000000004	5.9095034825339905
PALLISTER-HALL SYNDROME	0.056097019000000005	5.606666344314529
HOLOPROSENCEPHALY 7	0.056097019000000005	5.606666344314529
NON-FUNCTIONING PITUITARY ADENOMA	0.056097019000000005	5.606666344314529
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.056097019000000005	5.606666344314529
ADENOHYPOPHYSITIS	0.055555600000000004	5.552553741905611
PANHYPOPHYSITIS	0.055555600000000004	5.552553741905611
POST-TRAUMATIC PITUITARY DEFICIENCY	0.055555600000000004	5.552553741905611
JOUBERT SYNDROME 26	0.055555600000000004	5.552553741905611
PANHYPOPITUITARISM, X-LINKED	0.055555600000000004	5.552553741905611
PALLISTER-HALL SYNDROME	0.055555600000000004	5.552553741905611
FUNCTIONING GONADOTROPIC ADENOMA	0.055555600000000004	5.552553741905611
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.03805423	3.803363786582033
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.03805423	3.803363786582033
CHROMOSOME 1P36 DELETION SYNDROME	0.036370949	3.6351267732975283
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.035971778999999995	3.5952313734250314
AICARDI SYNDROME	0.03582953	3.581014170888612
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.035024219	3.500526648362571
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.035024219	3.500526648362571
COG5-CDG	0.035024219	3.500526648362571
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.035024219	3.500526648362571
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.035024219	3.500526648362571
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.035024219	3.500526648362571
ADNP SYNDROME	0.035024219	3.500526648362571
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.0344828	3.4464140459536536
AMISH INFANTILE EPILEPSY SYNDROME	0.0344828	3.4464140459536536
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.0344828	3.4464140459536536
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.0344828	3.4464140459536536
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.0344828	3.4464140459536536
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.0344828	3.4464140459536536
GABRIELE-DE VRIES SYNDROME	0.0344828	3.4464140459536536
SCHINZEL-GIEDION SYNDROME	0.0344828	3.4464140459536536
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.0344828	3.4464140459536536
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.0344828	3.4464140459536536
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.0344828	3.4464140459536536
CEREBROFACIOARTICULAR SYNDROME	0.0344828	3.4464140459536536
OROFACIODIGITAL SYNDROME TYPE 14	0.0344828	3.4464140459536536
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.0344828	3.4464140459536536
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.0344828	3.4464140459536536
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.0344828	3.4464140459536536
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.0344828	3.4464140459536536
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	3.2781770326691495
TUBEROUS SCLEROSIS-1	0.032799519	3.2781770326691495
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	3.2781770326691495
PEHO SYNDROME	0.0322581	3.224064430260233
ALG13-CDG	0.0322581	3.224064430260233
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0322581	3.224064430260233
WEST SYNDROME	0.0322581	3.224064430260233
TUBEROUS SCLEROSIS COMPLEX	0.0322581	3.224064430260233
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.0322581	3.224064430260233
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.0322581	3.224064430260233
UNILATERAL POLYMICROGYRIA	0.0322581	3.224064430260233
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.0322581	3.224064430260233
BILATERAL POLYMICROGYRIA	0.0322581	3.224064430260233
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	3.224064430260233
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.0322581	3.224064430260233
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.0322581	3.224064430260233
EARLY MYOCLONIC ENCEPHALOPATHY	0.0322581	3.224064430260233
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.0322581	3.224064430260233
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0322581	3.224064430260233
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.0322581	3.224064430260233
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.0322581	3.224064430260233
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.0322581	3.224064430260233
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.0322581	3.224064430260233
AICARDI SYNDROME; AIC	0.0322581	3.224064430260233
SLC35A2-CDG	0.0322581	3.224064430260233
OCULOCEREBRORENAL SYNDROME OF LOWE	0.031139849	3.1122998417319896
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.031139848999999997	3.112299841731989
WOLFRAM SYNDROME	0.031139848999999997	3.112299841731989
HOLOPROSENCEPHALY 2; HPE2	0.031139848999999997	3.112299841731989
PROTEUS SYNDROME	0.027568419	2.755350101103611
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.027568419	2.755350101103611
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.027568419	2.755350101103611
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.027568419	2.755350101103611
CENTRAL DIABETES INSIPIDUS	0.027568419	2.755350101103611
HOLOPROSENCEPHALY 1; HPE1	0.027568419	2.755350101103611
GRANULOMATOSIS WITH POLYANGIITIS	0.027568419	2.755350101103611
WEBB-DATTANI SYNDROME; WEDAS	0.027568419	2.755350101103611
FABRY DISEASE	0.027568419	2.755350101103611
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.027027	2.7012374986946943
SARCOIDOSIS	0.027027	2.7012374986946943
GIANT CELL ARTERITIS	0.027027	2.7012374986946943
ERDHEIM-CHESTER DISEASE	0.027027	2.7012374986946943
GROWTH HORMONE INSENSITIVITY SYNDROME	0.027027	2.7012374986946943
14Q22Q23 MICRODELETION SYNDROME	0.027027	2.7012374986946943
ALSTROM SYNDROME; ALMS	0.027027	2.7012374986946943
HARTSFIELD SYNDROME; HRTFDS	0.027027	2.7012374986946943
SEPTOOPTIC DYSPLASIA	0.027027	2.7012374986946943
NELSON SYNDROME	0.027027	2.7012374986946943
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.027027	2.7012374986946943
XANTHOMA DISSEMINATUM	0.027027	2.7012374986946943
ACQUIRED CENTRAL DIABETES INSIPIDUS	0.027027	2.7012374986946943
KAGAMI-OGATA SYNDROME	0.012516209	1.2509436153587163
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.012516209	1.2509436153587163
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.012516209	1.2509436153587163
FG SYNDROME TYPE 1	0.012516209	1.2509436153587163
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.012516209	1.2509436153587163
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.012516209	1.2509436153587163
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.012516209	1.2509436153587163
EMANUEL SYNDROME	0.012516209	1.2509436153587163
JACOBSEN SYNDROME	0.012516209	1.2509436153587163
SILVER-RUSSELL SYNDROME	0.01197479	1.1968310129497999
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.01197479	1.1968310129497999
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.01197479	1.1968310129497999
DISTAL MONOSOMY 10Q	0.008944779	0.8939938747303375
KAGAMI-OGATA SYNDROME	0.008944779	0.8939938747303375
GAUCHER DISEASE, PERINATAL LETHAL	0.008944779	0.8939938747303375
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.008944779	0.8939938747303375
GALLOWAY-MOWAT SYNDROME	0.008944779	0.8939938747303375
CORNELIA DE LANGE SYNDROME	0.008944779	0.8939938747303375
ADAMS-OLIVER SYNDROME	0.008944779	0.8939938747303375
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.008944779	0.8939938747303375
INFANTILE SIALIC ACID STORAGE DISEASE	0.008944779	0.8939938747303375
PELIZAEUS-MERZBACHER DISEASE	0.008944779	0.8939938747303375
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.008944779	0.8939938747303375
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.008944779	0.8939938747303375
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.008944779	0.8939938747303375
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.008944779	0.8939938747303375
CONGENITAL TOXOPLASMOSIS	0.008944779	0.8939938747303375
ZELLWEGER SYNDROME	0.008944779	0.8939938747303375
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.008944779	0.8939938747303375
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.008944779	0.8939938747303375
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.8939938747303375
TEMPLE SYNDROME	0.00840336	0.8398812723214211
DISTAL MONOSOMY 17Q	0.00840336	0.8398812723214211
TYSHCHENKO SYNDROME	0.00840336	0.8398812723214211
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.8398812723214211
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.8398812723214211
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.8398812723214211
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.8398812723214211
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.8398812723214211
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00840336	0.8398812723214211
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.8398812723214211
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.8398812723214211
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00840336	0.8398812723214211
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00840336	0.8398812723214211
PEDIATRIC-ONSET GRAVES DISEASE	0.00840336	0.8398812723214211
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.00840336	0.8398812723214211
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.8398812723214211
CONGENITAL ENTEROVIRUS INFECTION	0.00840336	0.8398812723214211
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00840336	0.8398812723214211
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.8398812723214211
BECKWITH-WIEDEMANN SYNDROME	0.00840336	0.8398812723214211
CINCA SYNDROME	0.00840336	0.8398812723214211
PEMPHIGOID GESTATIONIS	0.00840336	0.8398812723214211
SCHISIS ASSOCIATION	0.00840336	0.8398812723214211
OMPHALOCELE	0.00840336	0.8398812723214211
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.8398812723214211
RESTRICTIVE DERMOPATHY, LETHAL	0.00840336	0.8398812723214211
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.8398812723214211
ROBERTS SYNDROME	0.00840336	0.8398812723214211
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.8398812723214211
CARDIOFACIOCUTANEOUS SYNDROME	0.00840336	0.8398812723214211
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.8398812723214211
EBSTEIN MALFORMATION	0.00840336	0.8398812723214211
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00840336	0.8398812723214211
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.00840336	0.8398812723214211
NEMALINE MYOPATHY 10	0.00840336	0.8398812723214211
ACITRETIN/ETRETINATE EMBRYOPATHY	0.00840336	0.8398812723214211
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.00840336	0.8398812723214211
TEMPLE SYNDROME	0.00840336	0.8398812723214211
ROIFMAN SYNDROME; RFMN	0.00840336	0.8398812723214211
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.00840336	0.8398812723214211
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.00840336	0.8398812723214211
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00840336	0.8398812723214211
FATCO SYNDROME	0.00840336	0.8398812723214211
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.8398812723214211
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.8398812723214211
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.8398812723214211
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.8398812723214211
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.8398812723214211
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.8398812723214211
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.8398812723214211
HYDROLETHALUS	0.00840336	0.8398812723214211
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	0.8398812723214211
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.8398812723214211
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.8398812723214211
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.8398812723214211
HEC SYNDROME	0.00840336	0.8398812723214211
GMS SYNDROME	0.00840336	0.8398812723214211
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.8398812723214211
VASCULAR EHLERS-DANLOS SYNDROME	0.00840336	0.8398812723214211
CLASSICAL EHLERS-DANLOS SYNDROME	0.00840336	0.8398812723214211
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.00840336	0.8398812723214211
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.8398812723214211
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.8398812723214211
RENAL TUBULAR DYSGENESIS	0.00840336	0.8398812723214211
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.00840336	0.8398812723214211
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00840336	0.8398812723214211
RETINOPATHY OF PREMATURITY	0.00840336	0.8398812723214211
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.8398812723214211
YUNIS-VARON SYNDROME	0.00840336	0.8398812723214211
COSTELLO SYNDROME; CSTLO	0.00840336	0.8398812723214211
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.8398812723214211
KNIEST-LIKE DYSPLASIA, LETHAL	0.00840336	0.8398812723214211
VACTERL/VATER ASSOCIATION	0.00840336	0.8398812723214211
DIAMOND-BLACKFAN ANEMIA 1	0.00840336	0.8398812723214211
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.8398812723214211
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.8398812723214211
CONGENITAL ANALBUMINEMIA	0.00840336	0.8398812723214211
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.8398812723214211
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.00840336	0.8398812723214211
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00840336	0.8398812723214211
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.004112849	0.41106234303729516
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.004112849	0.41106234303729516
HEREDITARY FRUCTOSE INTOLERANCE	0.004112849	0.41106234303729516
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.004112849	0.41106234303729516
RETT SYNDROME; RTT	0.004112849	0.41106234303729516
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.004112849	0.41106234303729516
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.004112849	0.41106234303729516
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.004112849	0.41106234303729516
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.004112849	0.41106234303729516
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.004112849	0.41106234303729516
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.004112849	0.41106234303729516
9Q33.3Q34.11 MICRODELETION SYNDROME	0.004112849	0.41106234303729516
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.004112849	0.41106234303729516
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.004112849	0.41106234303729516
SMITH-MAGENIS SYNDROME; SMS	0.004112849	0.41106234303729516
SMITH-MAGENIS SYNDROME	0.004112849	0.41106234303729516
HYPOPHOSPHATASIA, INFANTILE	0.004112849	0.41106234303729516
LOWE OCULOCEREBRORENAL SYNDROME	0.004112849	0.41106234303729516
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.004112849	0.41106234303729516
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.004112849	0.41106234303729516
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.004112849	0.41106234303729516
KLEEFSTRA SYNDROME	0.004112849	0.41106234303729516
ALEXANDER DISEASE	0.004112849	0.41106234303729516
22Q11.2 DELETION SYNDROME	0.004112849	0.41106234303729516
ACUTE ADRENAL INSUFFICIENCY	0.004112849	0.41106234303729516
DDOST-CDG	0.004112849	0.41106234303729516
ANGELMAN SYNDROME	0.004112849	0.41106234303729516
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.004112849	0.41106234303729516
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.004112849	0.41106234303729516
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.004112849	0.41106234303729516
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.004112849	0.41106234303729516
PAROXYSMAL EXTREME PAIN DISORDER	0.004112849	0.41106234303729516
KAPUR-TORIELLO SYNDROME	0.004112849	0.41106234303729516
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.004112849	0.41106234303729516
48,XXXY SYNDROME	0.004112849	0.41106234303729516
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.004112849	0.41106234303729516
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.004112849	0.41106234303729516
NEPHROGENIC DIABETES INSIPIDUS	0.004112849	0.41106234303729516
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.004112849	0.41106234303729516
EMANUEL SYNDROME	0.004112849	0.41106234303729516
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.004112849	0.41106234303729516
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.004112849	0.41106234303729516
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.004112849	0.41106234303729516
2Q23.1 MICRODELETION SYNDROME	0.004112849	0.41106234303729516
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.004112849	0.41106234303729516
RETT SYNDROME, CONGENITAL VARIANT	0.004112849	0.41106234303729516
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.004112849	0.41106234303729516
ADIPOSIS DOLOROSA	0.004112849	0.41106234303729516
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.004112849	0.41106234303729516
PITT-HOPKINS SYNDROME	0.004112849	0.41106234303729516
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.004112849	0.41106234303729516
FAMILIAL MEDITERRANEAN FEVER	0.004112849	0.41106234303729516
611961 STEVENSON-CAREY SYNDROME	0.004112849	0.41106234303729516
PRADER-WILLI-LIKE SYNDROME	0.004112849	0.41106234303729516
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.004112849	0.41106234303729516
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.004112849	0.41106234303729516
DESANTO-SHINAWI SYNDROME	0.004112849	0.41106234303729516
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.004112849	0.41106234303729516
ADDISON DISEASE	0.004112849	0.41106234303729516
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.004112849	0.41106234303729516
1P36 DELETION SYNDROME	0.004112849	0.41106234303729516
MOWAT-WILSON SYNDROME; MOWS	0.004112849	0.41106234303729516
FAMILIAL COLORECTAL CANCER TYPE X	0.004112849	0.41106234303729516
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.004112849	0.41106234303729516
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.004112849	0.41106234303729516
CHROMOSOME 19P13.13 DELETION SYNDROME	0.004112849	0.41106234303729516
49,XXXXY SYNDROME	0.004112849	0.41106234303729516
WIEDEMANN-STEINER SYNDROME; WDSTS	0.004112849	0.41106234303729516
PROPIONIC ACIDEMIA	0.004112849	0.41106234303729516
TEMPLE-BARAITSER SYNDROME	0.004112849	0.41106234303729516
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.004112849	0.41106234303729516
MOWAT-WILSON SYNDROME	0.004112849	0.41106234303729516
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.004112849	0.41106234303729516
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.004112849	0.41106234303729516
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.004112849	0.41106234303729516
ACUTE INTERMITTENT PORPHYRIA	0.004112849	0.41106234303729516
RUBINSTEIN-TAYBI SYNDROME	0.004112849	0.41106234303729516
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.004112849	0.41106234303729516
HEREDITARY COPROPORPHYRIA	0.004112849	0.41106234303729516
PORPHYRIA VARIEGATA	0.004112849	0.41106234303729516
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.004112849	0.41106234303729516
XQ28 (MECP2) DUPLICATION	0.004112849	0.41106234303729516
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.004112849	0.41106234303729516
TRISOMY 8P	0.004112849	0.41106234303729516
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.004112849	0.41106234303729516
GITELMAN SYNDROME	0.004112849	0.41106234303729516
C SYNDROME	0.004112849	0.41106234303729516
PITT-HOPKINS SYNDROME	0.004112849	0.41106234303729516
LYNCH SYNDROME	0.004112849	0.41106234303729516
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.004112849	0.41106234303729516
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.004112849	0.41106234303729516
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.004112849	0.41106234303729516
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.004112849	0.41106234303729516
SCHAAF-YANG SYNDROME; SHFYNG	0.004112849	0.41106234303729516
48,XXYY SYNDROME	0.004112849	0.41106234303729516
PORPHYRIA	0.004112849	0.41106234303729516
AUTISM, SUSCEPTIBILITY TO, 18	0.004112849	0.41106234303729516
YOUNG-ONSET PARKINSON DISEASE	0.00357143	0.35694974062837875
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00357143	0.35694974062837875
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.00357143	0.35694974062837875
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00357143	0.35694974062837875
COFFIN-SIRIS SYNDROME 6; CSS6	0.00357143	0.35694974062837875
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00357143	0.35694974062837875
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.00357143	0.35694974062837875
13Q12.3 MICRODELETION SYNDROME	0.00357143	0.35694974062837875
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.00357143	0.35694974062837875
LAMBERT-EATON MYASTHENIC SYNDROME	0.00357143	0.35694974062837875
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.00357143	0.35694974062837875
OCHOA SYNDROME	0.00357143	0.35694974062837875
PURE AUTONOMIC FAILURE	0.00357143	0.35694974062837875
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00357143	0.35694974062837875
CAP POLYPOSIS	0.00357143	0.35694974062837875
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00357143	0.35694974062837875
CONGENITAL HYPOTHYROIDISM	0.00357143	0.35694974062837875
POLYMYOSITIS	0.00357143	0.35694974062837875
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00357143	0.35694974062837875
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00357143	0.35694974062837875
PARKINSON DISEASE, LATE-ONSET; PD	0.00357143	0.35694974062837875
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00357143	0.35694974062837875
FLOATING-HARBOR SYNDROME	0.00357143	0.35694974062837875
ATHYREOSIS	0.00357143	0.35694974062837875
UROFACIAL SYNDROME	0.00357143	0.35694974062837875
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.00357143	0.35694974062837875
AU-KLINE SYNDROME; AUKS	0.00357143	0.35694974062837875
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.00357143	0.35694974062837875
IATROGENIC BOTULISM	0.00357143	0.35694974062837875
INHALATIONAL BOTULISM	0.00357143	0.35694974062837875
GASTROINTESTINAL STROMAL TUMOR	0.00357143	0.35694974062837875
GRFOMA	0.00357143	0.35694974062837875
ERYTHERMALGIA, PRIMARY	0.00357143	0.35694974062837875
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00357143	0.35694974062837875
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.00357143	0.35694974062837875
MULTIPLE SYSTEM ATROPHY	0.00357143	0.35694974062837875
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.00357143	0.35694974062837875
FAMILIAL THYROID DYSHORMONOGENESIS	0.00357143	0.35694974062837875
THYROTOXIC PERIODIC PARALYSIS	0.00357143	0.35694974062837875
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.00357143	0.35694974062837875
ATTRV30M AMYLOIDOSIS	0.00357143	0.35694974062837875
TOWNES-BROCKS SYNDROME	0.00357143	0.35694974062837875
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00357143	0.35694974062837875
JUVENILE DERMATOMYOSITIS	0.00357143	0.35694974062837875
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.00357143	0.35694974062837875
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00357143	0.35694974062837875
PRIMARY PARATHYROID HYPERPLASIA	0.00357143	0.35694974062837875
THYROID HEMIAGENESIS	0.00357143	0.35694974062837875
VISCERAL MYOPATHY; VSCM	0.00357143	0.35694974062837875
GITELMAN SYNDROME	0.00357143	0.35694974062837875
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.00357143	0.35694974062837875
KAPUR-TORIELLO SYNDROME	0.00357143	0.35694974062837875
THYROID HYPOPLASIA	0.00357143	0.35694974062837875
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00357143	0.35694974062837875
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00357143	0.35694974062837875
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00357143	0.35694974062837875
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.00357143	0.35694974062837875
INFANTILE DYSTONIA-PARKINSONISM	0.00357143	0.35694974062837875
PROPIONIC ACIDEMIA	0.00357143	0.35694974062837875
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00357143	0.35694974062837875
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.00357143	0.35694974062837875
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.00357143	0.35694974062837875
FOODBORNE BOTULISM	0.00357143	0.35694974062837875
MYXEDEMA	0.00357143	0.35694974062837875
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.00357143	0.35694974062837875
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00357143	0.35694974062837875
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00357143	0.35694974062837875
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.00357143	0.35694974062837875
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.00357143	0.35694974062837875
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00357143	0.35694974062837875
NIEMANN-PICK DISEASE, TYPE A	0.00357143	0.35694974062837875
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.00357143	0.35694974062837875
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00357143	0.35694974062837875
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00357143	0.35694974062837875
WAARDENBURG-SHAH SYNDROME	0.00357143	0.35694974062837875
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.00357143	0.35694974062837875
PERMANENT CONGENITAL HYPOTHYROIDISM	0.00357143	0.35694974062837875
PARATHYROID CARCINOMA	0.00357143	0.35694974062837875
PERIPHERAL HYPOTHYROIDISM	0.00357143	0.35694974062837875
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.00357143	0.35694974062837875
HIRSCHSPRUNG DISEASE	0.00357143	0.35694974062837875
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.00357143	0.35694974062837875
BOTULISM	0.00357143	0.35694974062837875
THYROID ECTOPIA	0.00357143	0.35694974062837875
19P13.3 MICRODUPLICATION SYNDROME	0.00357143	0.35694974062837875
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00357143	0.35694974062837875
NK-CELL ENTEROPATHY	0.00357143	0.35694974062837875
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00357143	0.35694974062837875
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.00357143	0.35694974062837875
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00357143	0.35694974062837875
TYPHOID	0.00357143	0.35694974062837875
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00357143	0.35694974062837875
WOUND BOTULISM	0.00357143	0.35694974062837875
INFANT BOTULISM	0.00357143	0.35694974062837875
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.00357143	0.35694974062837875
UROFACIAL SYNDROME 2	0.00357143	0.35694974062837875
TURCOT SYNDROME WITH POLYPOSIS	0.00357143	0.35694974062837875
WILLIAMS SYNDROME	0.00357143	0.35694974062837875
NEUROFERRITINOPATHY	0.00357143	0.35694974062837875
SOMATOSTATINOMA	0.00357143	0.35694974062837875
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.00357143	0.35694974062837875
WHITE-SUTTON SYNDROME; WHSUS	0.00357143	0.35694974062837875
MALT LYMPHOMA	0.00357143	0.35694974062837875
LIDDLE SYNDROME	0.00357143	0.35694974062837875
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00357143	0.35694974062837875
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.00357143	0.35694974062837875
ANAL SPHINCTER DYSPLASIA; ASDP	0.00357143	0.35694974062837875
PUDENDAL NEURALGIA	0.00357143	0.35694974062837875
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00357143	0.35694974062837875
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00357143	0.35694974062837875
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00357143	0.35694974062837875
FG SYNDROME 2; FGS2	0.00357143	0.35694974062837875
PRUNE BELLY SYNDROME	0.00357143	0.35694974062837875
MELAS	0.00357143	0.35694974062837875
300270 ADRENOMYODYSTROPHY	0.00357143	0.35694974062837875
SECONDARY SHORT BOWEL SYNDROME	0.00357143	0.35694974062837875
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00357143	0.35694974062837875
ADIPOSIS DOLOROSA	0.00357143	0.35694974062837875
PERITONEAL CYSTIC MESOTHELIOMA	0.00357143	0.35694974062837875
PRIMARY PERITONEAL CARCINOMA	0.00357143	0.35694974062837875
PANHYPOPITUITARISM	0.00357143	0.35694974062837875
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00357143	0.35694974062837875
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00357143	0.35694974062837875
GLUCAGONOMA	0.00357143	0.35694974062837875
PPOMA	0.00357143	0.35694974062837875
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.00357143	0.35694974062837875
HINMAN SYNDROME	0.00357143	0.35694974062837875
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00357143	0.35694974062837875
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00357143	0.35694974062837875
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00357143	0.35694974062837875
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00357143	0.35694974062837875
COFFIN-SIRIS SYNDROME 7; CSS7	0.00357143	0.35694974062837875
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00357143	0.35694974062837875
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.00357143	0.35694974062837875
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.00357143	0.35694974062837875
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.00357143	0.35694974062837875
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.00357143	0.35694974062837875
PSEUDOMYXOMA PERITONEI	0.00357143	0.35694974062837875
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.00357143	0.35694974062837875
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00357143	0.35694974062837875
PORPHYRIA VARIEGATA	0.00357143	0.35694974062837875
RHEUMATIC FEVER	0.00357143	0.35694974062837875
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00357143	0.35694974062837875
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.00357143	0.35694974062837875
WILLIAMS-BEUREN SYNDROME; WBS	0.00357143	0.35694974062837875
SMITH-FINEMAN-MYERS SYNDROME	0.000541419	0.05411260240891637
MOYNAHAN SYNDROME	0.000541419	0.05411260240891637
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.05411260240891637
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.05411260240891637
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.05411260240891637
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.000541419	0.05411260240891637
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.05411260240891637
AICA-RIBOSIDURIA	0.000541419	0.05411260240891637
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.000541419	0.05411260240891637
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.000541419	0.05411260240891637
THANATOPHORIC DYSPLASIA	0.000541419	0.05411260240891637
MICROSPORIDIOSIS	0.000541419	0.05411260240891637
1Q21.1 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
21Q22.11Q22.12 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
OCULODENTODIGITAL DYSPLASIA	0.000541419	0.05411260240891637
20Q13.33 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
20P12.3 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.000541419	0.05411260240891637
L1 SYNDROME	0.000541419	0.05411260240891637
10Q22.3Q23.3 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.05411260240891637
XP21 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.05411260240891637
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.000541419	0.05411260240891637
7Q11.23 MICRODUPLICATION SYNDROME	0.000541419	0.05411260240891637
8P INVERTED DUPLICATION/DELETION SYNDROME	0.000541419	0.05411260240891637
CITRULLINEMIA TYPE I	0.000541419	0.05411260240891637
SUBEPENDYMOMA	0.000541419	0.05411260240891637
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.05411260240891637
CITRULLINEMIA TYPE II	0.000541419	0.05411260240891637
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.000541419	0.05411260240891637
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.05411260240891637
JUVENILE HUNTINGTON DISEASE	0.000541419	0.05411260240891637
MOYAMOYA DISEASE	0.000541419	0.05411260240891637
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.000541419	0.05411260240891637
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.000541419	0.05411260240891637
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.000541419	0.05411260240891637
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.000541419	0.05411260240891637
PARTINGTON SYNDROME	0.000541419	0.05411260240891637
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.05411260240891637
EPENDYMOMA	0.000541419	0.05411260240891637
CK SYNDROME	0.000541419	0.05411260240891637
3Q29 MICRODUPLICATION SYNDROME	0.000541419	0.05411260240891637
6Q25 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
14Q12 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.000541419	0.05411260240891637
MICRO SYNDROME	0.000541419	0.05411260240891637
MOMO SYNDROME	0.000541419	0.05411260240891637
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.05411260240891637
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000541419	0.05411260240891637
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.05411260240891637
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
15Q14 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
MONOSOMY 9P	0.000541419	0.05411260240891637
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.05411260240891637
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.05411260240891637
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.05411260240891637
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.05411260240891637
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.05411260240891637
2Q31.1 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.05411260240891637
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.000541419	0.05411260240891637
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.000541419	0.05411260240891637
DISTAL 16P11.2 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
8P11.2 DELETION SYNDROME	0.000541419	0.05411260240891637
16Q24.3 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
RFT1-CDG	0.000541419	0.05411260240891637
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.05411260240891637
COG8-CDG	0.000541419	0.05411260240891637
1Q21.1 MICRODUPLICATION SYNDROME	0.000541419	0.05411260240891637
15Q24 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
1Q41Q42 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.05411260240891637
OROFACIODIGITAL SYNDROME TYPE 6	0.000541419	0.05411260240891637
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.000541419	0.05411260240891637
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.000541419	0.05411260240891637
OROFACIODIGITAL SYNDROME TYPE 1	0.000541419	0.05411260240891637
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.05411260240891637
17Q12 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.000541419	0.05411260240891637
8P23.1 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.05411260240891637
19P13.12 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
PINEOBLASTOMA	0.000541419	0.05411260240891637
ALG1-CDG	0.000541419	0.05411260240891637
CENTRAL BILATERAL MACROGYRIA	0.000541419	0.05411260240891637
CHÉDIAK-HIGASHI SYNDROME	0.000541419	0.05411260240891637
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.05411260240891637
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.05411260240891637
DISTAL TRISOMY 15Q	0.000541419	0.05411260240891637
MOSAIC TRISOMY 14	0.000541419	0.05411260240891637
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.05411260240891637
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.000541419	0.05411260240891637
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.05411260240891637
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.05411260240891637
WOLCOTT-RALLISON SYNDROME	0.000541419	0.05411260240891637
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.05411260240891637
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.05411260240891637
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.05411260240891637
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.000541419	0.05411260240891637
2P21 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
DISTAL MONOSOMY 7Q36	0.000541419	0.05411260240891637
DISTAL MONOSOMY 3P	0.000541419	0.05411260240891637
22Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.05411260240891637
FAMILIAL DYSAUTONOMIA	0.000541419	0.05411260240891637
DYSEQUILIBRIUM SYNDROME	0.000541419	0.05411260240891637
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000541419	0.05411260240891637
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.05411260240891637
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.000541419	0.05411260240891637
FRONTAL ENCEPHALOCELE	0.000541419	0.05411260240891637
COHEN SYNDROME	0.000541419	0.05411260240891637
COFFIN-LOWRY SYNDROME	0.000541419	0.05411260240891637
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.000541419	0.05411260240891637
COCKAYNE SYNDROME	0.000541419	0.05411260240891637
BOHRING-OPITZ SYNDROME	0.000541419	0.05411260240891637
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.05411260240891637
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.05411260240891637
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000541419	0.05411260240891637
THANATOPHORIC DYSPLASIA TYPE 1	0.000541419	0.05411260240891637
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.05411260240891637
ADRENOMYODYSTROPHY	0.000541419	0.05411260240891637
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.05411260240891637
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.000541419	0.05411260240891637
SPINOCEREBELLAR ATAXIA TYPE 13	0.000541419	0.05411260240891637
2Q24 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
MONOSOMY 18Q	0.000541419	0.05411260240891637
DISTAL MONOSOMY 15Q	0.000541419	0.05411260240891637
NIPAH VIRUS DISEASE	0.000541419	0.05411260240891637
COFS SYNDROME	0.000541419	0.05411260240891637
COFFIN-SIRIS SYNDROME	0.000541419	0.05411260240891637
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.000541419	0.05411260240891637
RING CHROMOSOME 22 SYNDROME	0.000541419	0.05411260240891637
RING CHROMOSOME 10 SYNDROME	0.000541419	0.05411260240891637
SECONDARY SYRINGOMYELIA	0.000541419	0.05411260240891637
XQ21 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.05411260240891637
CANAVAN DISEASE	0.000541419	0.05411260240891637
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.05411260240891637
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.05411260240891637
ISOLATED CEREBELLAR AGENESIS	0.000541419	0.05411260240891637
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.000541419	0.05411260240891637
17Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.05411260240891637
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.000541419	0.05411260240891637
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.05411260240891637
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.000541419	0.05411260240891637
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.05411260240891637
MULTIPLE CARBOXYLASE DEFICIENCY	0.000541419	0.05411260240891637
DERMOTRICHIC SYNDROME	0.000541419	0.05411260240891637
VICI SYNDROME	0.000541419	0.05411260240891637
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.05411260240891637
ROSAÏ-DORFMAN DISEASE	0.000541419	0.05411260240891637
HADDAD SYNDROME	0.000541419	0.05411260240891637
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.05411260240891637
HUNTINGTON DISEASE-LIKE 1	0.000541419	0.05411260240891637
KNOBLOCH SYNDROME	0.000541419	0.05411260240891637
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.05411260240891637
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.000541419	0.05411260240891637
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.05411260240891637
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.05411260240891637
CRYPTOCOCCOSIS	0.000541419	0.05411260240891637
CRISPONI SYNDROME	0.000541419	0.05411260240891637
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.05411260240891637
LASSA FEVER	0.000541419	0.05411260240891637
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.05411260240891637
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.000541419	0.05411260240891637
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.000541419	0.05411260240891637
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.05411260240891637
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.05411260240891637
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.05411260240891637
NON-DISTAL MONOSOMY 20Q	0.000541419	0.05411260240891637
5Q14.3 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.000541419	0.05411260240891637
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.05411260240891637
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.000541419	0.05411260240891637
RECOMBINANT 8 SYNDROME	0.000541419	0.05411260240891637
KOOLEN-DE VRIES SYNDROME	0.000541419	0.05411260240891637
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.000541419	0.05411260240891637
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.05411260240891637
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.000541419	0.05411260240891637
PITT-HOPKINS-LIKE SYNDROME	0.000541419	0.05411260240891637
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.05411260240891637
MATERNAL PHENYLKETONURIA	0.000541419	0.05411260240891637
JOUBERT SYNDROME WITH RENAL DEFECT	0.000541419	0.05411260240891637
JOUBERT SYNDROME WITH OCULAR DEFECT	0.000541419	0.05411260240891637
CONGENITAL HYDROCEPHALUS	0.000541419	0.05411260240891637
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.05411260240891637
HYDRANENCEPHALY	0.000541419	0.05411260240891637
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.05411260240891637
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.000541419	0.05411260240891637
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.000541419	0.05411260240891637
DISTAL MONOSOMY 19P13.3	0.000541419	0.05411260240891637
LOWRY-MACLEAN SYNDROME	0.000541419	0.05411260240891637
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.000541419	0.05411260240891637
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.000541419	0.05411260240891637
CHOREOACANTHOCYTOSIS	0.000541419	0.05411260240891637
4Q21 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
15Q11Q13 MICRODUPLICATION SYNDROME	0.000541419	0.05411260240891637
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.05411260240891637
DUBOWITZ SYNDROME	0.000541419	0.05411260240891637
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.05411260240891637
KBG SYNDROME	0.000541419	0.05411260240891637
DUANE RETRACTION SYNDROME	0.000541419	0.05411260240891637
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.05411260240891637
SANJAD-SAKATI SYNDROME	0.000541419	0.05411260240891637
KABUKI SYNDROME	0.000541419	0.05411260240891637
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.000541419	0.05411260240891637
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.05411260240891637
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.000541419	0.05411260240891637
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.05411260240891637
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000541419	0.05411260240891637
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.000541419	0.05411260240891637
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.000541419	0.05411260240891637
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.05411260240891637
FRYNS SYNDROME	0.000541419	0.05411260240891637
CRIGLER-NAJJAR SYNDROME	0.000541419	0.05411260240891637
FOIX-CHAVANY-MARIE SYNDROME	0.000541419	0.05411260240891637
FLYNN-AIRD SYNDROME	0.000541419	0.05411260240891637
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.05411260240891637
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.05411260240891637
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.05411260240891637
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.05411260240891637
COWDEN SYNDROME	0.000541419	0.05411260240891637
ACROCARDIOFACIAL SYNDROME	0.000541419	0.05411260240891637
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.000541419	0.05411260240891637
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.05411260240891637
EAST SYNDROME	0.000541419	0.05411260240891637
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.05411260240891637
INSULINOMA	0.000541419	0.05411260240891637
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.05411260240891637
OPTIC PATHWAY GLIOMA	0.000541419	0.05411260240891637
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.05411260240891637
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.000541419	0.05411260240891637
NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.05411260240891637
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.05411260240891637
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.05411260240891637
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.05411260240891637
DONNAI-BARROW SYNDROME	0.000541419	0.05411260240891637
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.000541419	0.05411260240891637
HENNEKAM SYNDROME	0.000541419	0.05411260240891637
HENNEKAM-BEEMER SYNDROME	0.000541419	0.05411260240891637
CYSTATHIONINURIA	0.000541419	0.05411260240891637
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.05411260240891637
HARTNUP DISEASE	0.000541419	0.05411260240891637
HARROD SYNDROME	0.000541419	0.05411260240891637
HALL-RIGGS SYNDROME	0.000541419	0.05411260240891637
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.000541419	0.05411260240891637
EPISODIC ATAXIA TYPE 6	0.000541419	0.05411260240891637
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.05411260240891637
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.05411260240891637
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.000541419	0.05411260240891637
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.05411260240891637
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.000541419	0.05411260240891637
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.000541419	0.05411260240891637
SCRUB TYPHUS	0.000541419	0.05411260240891637
FREE SIALIC ACID STORAGE DISEASE	0.000541419	0.05411260240891637
16P13.2 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
CAMOS SYNDROME	0.000541419	0.05411260240891637
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.05411260240891637
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.05411260240891637
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.000541419	0.05411260240891637
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.000541419	0.05411260240891637
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.000541419	0.05411260240891637
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.000541419	0.05411260240891637
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.05411260240891637
MONOSOMY 22Q13.3	0.000541419	0.05411260240891637
ENCEPHALITIS LETHARGICA	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.000541419	0.05411260240891637
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.000541419	0.05411260240891637
KALLMANN SYNDROME	0.000541419	0.05411260240891637
JOUBERT SYNDROME	0.000541419	0.05411260240891637
TAY-SACHS DISEASE	0.000541419	0.05411260240891637
SLC39A8-CDG	0.000541419	0.05411260240891637
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.000541419	0.05411260240891637
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.000541419	0.05411260240891637
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.000541419	0.05411260240891637
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.05411260240891637
47,XYY SYNDROME	0.000541419	0.05411260240891637
SCLERODERMA	0.000541419	0.05411260240891637
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.05411260240891637
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.000541419	0.05411260240891637
XQ25 MICRODUPLICATION SYNDROME	0.000541419	0.05411260240891637
WHIM SYNDROME	0.000541419	0.05411260240891637
SIALIDOSIS TYPE 1	0.000541419	0.05411260240891637
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.05411260240891637
SJÖGREN-LARSSON SYNDROME	0.000541419	0.05411260240891637
ETHYLMALONIC ENCEPHALOPATHY	0.000541419	0.05411260240891637
MAPLE SYRUP URINE DISEASE	0.000541419	0.05411260240891637
AICARDI-GOUTIÈRES SYNDROME	0.000541419	0.05411260240891637
SMITH-LEMLI-OPITZ SYNDROME	0.000541419	0.05411260240891637
8Q24.3 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000541419	0.05411260240891637
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.05411260240891637
SNEDDON SYNDROME	0.000541419	0.05411260240891637
LEIGH SYNDROME	0.000541419	0.05411260240891637
ISOLATED SPINA BIFIDA	0.000541419	0.05411260240891637
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.000541419	0.05411260240891637
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.000541419	0.05411260240891637
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.000541419	0.05411260240891637
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.000541419	0.05411260240891637
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.000541419	0.05411260240891637
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.05411260240891637
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.05411260240891637
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.000541419	0.05411260240891637
HYPOPHOSPHATASIA	0.000541419	0.05411260240891637
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.05411260240891637
KEPPEN-LUBINSKY SYNDROME	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.05411260240891637
MEHMO SYNDROME	0.000541419	0.05411260240891637
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.000541419	0.05411260240891637
PHACE SYNDROME	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.05411260240891637
CONO-SPONDYLAR DYSPLASIA	0.000541419	0.05411260240891637
MALAN OVERGROWTH SYNDROME	0.000541419	0.05411260240891637
HYPERPROLINEMIA TYPE 1	0.000541419	0.05411260240891637
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.05411260240891637
DYSTONIA-APHONIA SYNDROME	0.000541419	0.05411260240891637
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.000541419	0.05411260240891637
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000541419	0.05411260240891637
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.000541419	0.05411260240891637
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.05411260240891637
NEONATAL ADRENOLEUKODYSTROPHY	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.000541419	0.05411260240891637
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.05411260240891637
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.05411260240891637
INCONTINENTIA PIGMENTI	0.000541419	0.05411260240891637
LATHOSTEROLOSIS	0.000541419	0.05411260240891637
ADENYLOSUCCINATE LYASE DEFICIENCY	0.000541419	0.05411260240891637
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.05411260240891637
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.000541419	0.05411260240891637
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000541419	0.05411260240891637
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.000541419	0.05411260240891637
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000541419	0.05411260240891637
GENITOPATELLAR SYNDROME	0.000541419	0.05411260240891637
KEUTEL SYNDROME	0.000541419	0.05411260240891637
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.05411260240891637
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.000541419	0.05411260240891637
FETAL GAUCHER DISEASE	0.000541419	0.05411260240891637
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.000541419	0.05411260240891637
11Q22.2Q22.3 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
PGM3-CDG	0.000541419	0.05411260240891637
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000541419	0.05411260240891637
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.05411260240891637
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.05411260240891637
6Q TERMINAL DELETION SYNDROME	0.000541419	0.05411260240891637
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.05411260240891637
RETT SYNDROME	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.000541419	0.05411260240891637
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.05411260240891637
MONOSOMY 9Q22.3	0.000541419	0.05411260240891637
INFANTILE REFSUM DISEASE	0.000541419	0.05411260240891637
RABIES	0.000541419	0.05411260240891637
PYRUVATE DEHYDROGENASE DEFICIENCY	0.000541419	0.05411260240891637
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.05411260240891637
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.05411260240891637
17Q24.2 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.05411260240891637
PRADER-WILLI SYNDROME	0.000541419	0.05411260240891637
SAETHRE-CHOTZEN SYNDROME	0.000541419	0.05411260240891637
ANGELMAN SYNDROME	0.000541419	0.05411260240891637
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.05411260240891637
FAMILIAL THROMBOCYTOSIS	0.000541419	0.05411260240891637
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.05411260240891637
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.000541419	0.05411260240891637
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.000541419	0.05411260240891637
MOGS-CDG	0.000541419	0.05411260240891637
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.05411260240891637
ALG9-CDG	0.000541419	0.05411260240891637
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.000541419	0.05411260240891637
MPDU1-CDG	0.000541419	0.05411260240891637
DPM1-CDG	0.000541419	0.05411260240891637
ALG3-CDG	0.000541419	0.05411260240891637
PMM2-CDG	0.000541419	0.05411260240891637
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.05411260240891637
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.000541419	0.05411260240891637
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.05411260240891637
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.05411260240891637
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.000541419	0.05411260240891637
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.05411260240891637
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000541419	0.05411260240891637
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.000541419	0.05411260240891637
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.05411260240891637
CLASSIC PHENYLKETONURIA	0.000541419	0.05411260240891637
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.05411260240891637
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.05411260240891637
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000541419	0.05411260240891637
EPISODIC ATAXIA TYPE 3	0.000541419	0.05411260240891637
DEND SYNDROME	0.000541419	0.05411260240891637
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.05411260240891637
GRISCELLI SYNDROME TYPE 1	0.000541419	0.05411260240891637
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.05411260240891637
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.000541419	0.05411260240891637
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.05411260240891637
CENTRONUCLEAR MYOPATHY	0.000541419	0.05411260240891637
CONGENITAL MYASTHENIC SYNDROME	0.000541419	0.05411260240891637
MYASTHENIA GRAVIS	0.000541419	0.05411260240891637
MUSCLE-EYE-BRAIN DISEASE	0.000541419	0.05411260240891637
MULTIPLE SULFATASE DEFICIENCY	0.000541419	0.05411260240891637
MUCOPOLYSACCHARIDOSIS TYPE 3	0.000541419	0.05411260240891637
MUCOPOLYSACCHARIDOSIS TYPE 2	0.000541419	0.05411260240891637
MICROPHTHALMIA, LENZ TYPE	0.000541419	0.05411260240891637
MENKES DISEASE	0.000541419	0.05411260240891637
CRANIOPHARYNGIOMA	0.000541419	0.05411260240891637
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.05411260240891637
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.05411260240891637
WYBURN-MASON SYNDROME	0.000541419	0.05411260240891637
SCHIZENCEPHALY	0.000541419	0.05411260240891637
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
MILLER-DIEKER SYNDROME	0.000541419	0.05411260240891637
LIPOID PROTEINOSIS	0.000541419	0.05411260240891637
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.000541419	0.05411260240891637
HEREDITARY METHEMOGLOBINEMIA	0.000541419	0.05411260240891637
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.05411260240891637
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.000541419	0.05411260240891637
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.05411260240891637
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.000541419	0.05411260240891637
DILATED CARDIOMYOPATHY WITH ATAXIA	0.000541419	0.05411260240891637
CEDNIK SYNDROME	0.000541419	0.05411260240891637
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.000541419	0.05411260240891637
ONDINE SYNDROME	0.000541419	0.05411260240891637
GRISCELLI SYNDROME TYPE 2	0.000541419	0.05411260240891637
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.05411260240891637
LHERMITTE-DUCLOS DISEASE	0.000541419	0.05411260240891637
LEBER CONGENITAL AMAUROSIS	0.000541419	0.05411260240891637
NORRIE DISEASE	0.000541419	0.05411260240891637
NEVUS COMEDONICUS SYNDROME	0.000541419	0.05411260240891637
RECURRENT ACUTE PANCREATITIS	0.000541419	0.05411260240891637
NIEMANN-PICK DISEASE TYPE C	0.000541419	0.05411260240891637
NARP SYNDROME	0.000541419	0.05411260240891637
ALSTRÖM SYNDROME	0.000541419	0.05411260240891637
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.05411260240891637
NEUROFIBROMATOSIS TYPE 1	0.000541419	0.05411260240891637
NETHERTON SYNDROME	0.000541419	0.05411260240891637
SANDHOFF DISEASE	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.000541419	0.05411260240891637
ISOLATED GLYCEROL KINASE DEFICIENCY	0.000541419	0.05411260240891637
NASU-HAKOLA DISEASE	0.000541419	0.05411260240891637
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.000541419	0.05411260240891637
SEVERE CANAVAN DISEASE	0.000541419	0.05411260240891637
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.000541419	0.05411260240891637
15Q OVERGROWTH SYNDROME	0.000541419	0.05411260240891637
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.000541419	0.05411260240891637
20P13 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
RUVALCABA SYNDROME	0.000541419	0.05411260240891637
NOCARDIOSIS	0.000541419	0.05411260240891637
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.05411260240891637
ATYPICAL RETT SYNDROME	0.000541419	0.05411260240891637
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.000541419	0.05411260240891637
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.000541419	0.05411260240891637
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.000541419	0.05411260240891637
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.05411260240891637
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000541419	0.05411260240891637
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.05411260240891637
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.05411260240891637
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.05411260240891637
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.05411260240891637
ALG2-CDG	0.000541419	0.05411260240891637
SYSTEMIC SCLEROSIS	0.000541419	0.05411260240891637
SIALURIA	0.000541419	0.05411260240891637
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.05411260240891637
WIEDEMANN-STEINER SYNDROME	0.000541419	0.05411260240891637
ARGININEMIA	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.000541419	0.05411260240891637
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.05411260240891637
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.05411260240891637
RENPENNING SYNDROME	0.000541419	0.05411260240891637
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.05411260240891637
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.05411260240891637
FOUNTAIN SYNDROME	0.000541419	0.05411260240891637
STURGE-WEBER SYNDROME	0.000541419	0.05411260240891637
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.05411260240891637
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.05411260240891637
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.000541419	0.05411260240891637
HEREDITARY HYPEREKPLEXIA	0.000541419	0.05411260240891637
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.000541419	0.05411260240891637
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.05411260240891637
HEREDITARY FOLATE MALABSORPTION	0.000541419	0.05411260240891637
RIFT VALLEY FEVER	0.000541419	0.05411260240891637
EBOLA HEMORRHAGIC FEVER	0.000541419	0.05411260240891637
LUJO HEMORRHAGIC FEVER	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.05411260240891637
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.000541419	0.05411260240891637
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.05411260240891637
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.05411260240891637
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.05411260240891637
PFEIFFER SYNDROME TYPE 2	0.000541419	0.05411260240891637
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.05411260240891637
PFEIFFER SYNDROME TYPE 3	0.000541419	0.05411260240891637
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.000541419	0.05411260240891637
XP22.13P22.2 DUPLICATION SYNDROME	0.000541419	0.05411260240891637
TYROSINEMIA TYPE 2	0.000541419	0.05411260240891637
THANATOPHORIC DYSPLASIA TYPE 2	0.000541419	0.05411260240891637
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.000541419	0.05411260240891637
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.000541419	0.05411260240891637
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.000541419	0.05411260240891637
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.05411260240891637
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.000541419	0.05411260240891637
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.05411260240891637
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.000541419	0.05411260240891637
ALG11-CDG	0.000541419	0.05411260240891637
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.05411260240891637
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.05411260240891637
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.05411260240891637
TARP SYNDROME	0.000541419	0.05411260240891637
ASPARTYLGLUCOSAMINURIA	0.000541419	0.05411260240891637
MEVALONIC ACIDURIA	0.000541419	0.05411260240891637
CONGENITAL RUBELLA SYNDROME	0.000541419	0.05411260240891637
RAMON SYNDROME	0.000541419	0.05411260240891637
QAZI-MARKOUIZOS SYNDROME	0.000541419	0.05411260240891637
FRAGILE X SYNDROME	0.000541419	0.05411260240891637
11P15.4 MICRODUPLICATION SYNDROME	0.000541419	0.05411260240891637
CEREBROTENDINOUS XANTHOMATOSIS	0.000541419	0.05411260240891637
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.000541419	0.05411260240891637
SPONTANEOUS PERIODIC HYPOTHERMIA	0.000541419	0.05411260240891637
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.000541419	0.05411260240891637
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.05411260240891637
PROLACTINOMA	0.000541419	0.05411260240891637
PORENCEPHALY	0.000541419	0.05411260240891637
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.000541419	0.05411260240891637
XERODERMA PIGMENTOSUM	0.000541419	0.05411260240891637
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.05411260240891637
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.000541419	0.05411260240891637
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.05411260240891637
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.05411260240891637
CRONKHITE-CANADA SYNDROME	0.000541419	0.05411260240891637
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.05411260240891637
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.05411260240891637
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.05411260240891637
SRD5A3-CDG	0.000541419	0.05411260240891637
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.000541419	0.05411260240891637
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.000541419	0.05411260240891637
GRISCELLI SYNDROME	0.000541419	0.05411260240891637
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.05411260240891637
SIMPSON-GOLABI-BEHMEL SYNDROME	0.000541419	0.05411260240891637
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.000541419	0.05411260240891637
SSR4-CDG	0.000541419	0.05411260240891637
STT3B-CDG	0.000541419	0.05411260240891637
STT3A-CDG	0.000541419	0.05411260240891637
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.05411260240891637
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000541419	0.05411260240891637
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.05411260240891637
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.05411260240891637
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.05411260240891637
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.05411260240891637
DISTAL MONOSOMY 1Q	0.000541419	0.05411260240891637
20Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.05411260240891637
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.05411260240891637
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.000541419	0.05411260240891637
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.000541419	0.05411260240891637
GLIOBLASTOMA	0.000541419	0.05411260240891637
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.05411260240891637
HSD10 DISEASE	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.05411260240891637
CLASSIC HOMOCYSTINURIA	0.000541419	0.05411260240891637
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.05411260240891637
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.000541419	0.05411260240891637
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.000541419	0.05411260240891637
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.000541419	0.05411260240891637
MEND SYNDROME	0.000541419	0.05411260240891637
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.05411260240891637
MAN1B1-CDG	0.000541419	0.05411260240891637
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.000541419	0.05411260240891637
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.05411260240891637
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.000541419	0.05411260240891637
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.05411260240891637
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000541419	0.05411260240891637
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.000541419	0.05411260240891637
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.000541419	0.05411260240891637
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.05411260240891637
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.05411260240891637
DISTAL TRISOMY 17Q	0.000541419	0.05411260240891637
TRISOMY 13	0.000541419	0.05411260240891637
TRISOMY X	0.000541419	0.05411260240891637
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.05411260240891637
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.05411260240891637
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.000541419	0.05411260240891637
THYROCEREBRORENAL SYNDROME	0.000541419	0.05411260240891637
TETRASOMY 9P	0.000541419	0.05411260240891637
TETRASOMY 5P	0.000541419	0.05411260240891637
TETRASOMY 18P	0.000541419	0.05411260240891637
DUPLICATION/INVERSION 15Q11	0.000541419	0.05411260240891637
MERCURY POISONING	0.000541419	0.05411260240891637
ISOVALERIC ACIDEMIA	0.000541419	0.05411260240891637
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.000541419	0.05411260240891637
TAKAYASU ARTERITIS	0.000541419	0.05411260240891637
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.05411260240891637
WALKER-WARBURG SYNDROME	0.000541419	0.05411260240891637
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.000541419	0.05411260240891637
FILIPPI SYNDROME	0.000541419	0.05411260240891637
VIRAL HEMORRHAGIC FEVER	0.000541419	0.05411260240891637
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000541419	0.05411260240891637
19P13.13 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.000541419	0.05411260240891637
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.05411260240891637
DPAGT1-CDG	0.000541419	0.05411260240891637
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000541419	0.05411260240891637
GM1 GANGLIOSIDOSIS	0.000541419	0.05411260240891637
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.000541419	0.05411260240891637
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.000541419	0.05411260240891637
GALACTOSEMIA	0.000541419	0.05411260240891637
GALACTOSIALIDOSIS	0.000541419	0.05411260240891637
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.05411260240891637
FUCOSIDOSIS	0.000541419	0.05411260240891637
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.05411260240891637
CHIME SYNDROME	0.000541419	0.05411260240891637
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.05411260240891637
WORSTER-DROUGHT SYNDROME	0.000541419	0.05411260240891637
TRIPLE A SYNDROME	0.000541419	0.05411260240891637
WILSON-TURNER SYNDROME	0.000541419	0.05411260240891637
SIALIDOSIS TYPE 2	0.000541419	0.05411260240891637
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.000541419	0.05411260240891637
WHIPPLE DISEASE	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.000541419	0.05411260240891637
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.05411260240891637
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.05411260240891637
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.05411260240891637
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.05411260240891637
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED 9	0.000541419	0.05411260240891637
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.05411260240891637
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.05411260240891637
RENPENNING SYNDROME 1; RENS1	0.000541419	0.05411260240891637
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.05411260240891637
MENKES DISEASE	0.000541419	0.05411260240891637
INCONTINENTIA PIGMENTI; IP	0.000541419	0.05411260240891637
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.000541419	0.05411260240891637
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.05411260240891637
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.05411260240891637
GLYCEROL KINASE DEFICIENCY; GKD	0.000541419	0.05411260240891637
HHHH SYNDROME	0.000541419	0.05411260240891637
PETTIGREW SYNDROME	0.000541419	0.05411260240891637
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.05411260240891637
COFFIN-LOWRY SYNDROME; CLS	0.000541419	0.05411260240891637
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000541419	0.05411260240891637
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.000541419	0.05411260240891637
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000541419	0.05411260240891637
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.000541419	0.05411260240891637
SHUKLA-VERNON SYNDROME; SHUVER	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.000541419	0.05411260240891637
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.05411260240891637
POTOCKI-SHAFFER SYNDROME	0.000541419	0.05411260240891637
OROFACIODIGITAL SYNDROME I; OFD1	0.000541419	0.05411260240891637
GURRIERI SYNDROME	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.000541419	0.05411260240891637
AYME-GRIPP SYNDROME; AYGRP	0.000541419	0.05411260240891637
TIMOTHY SYNDROME; TS	0.000541419	0.05411260240891637
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000541419	0.05411260240891637
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.05411260240891637
CHROMOSOME 2Q37 DELETION SYNDROME	0.000541419	0.05411260240891637
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.05411260240891637
CODAS SYNDROME	0.000541419	0.05411260240891637
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.05411260240891637
BAND HETEROTOPIA; BH	0.000541419	0.05411260240891637
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.05411260240891637
OCULOECTODERMAL SYNDROME; OES	0.000541419	0.05411260240891637
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.05411260240891637
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.000541419	0.05411260240891637
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000541419	0.05411260240891637
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.000541419	0.05411260240891637
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.05411260240891637
CYCLIC VOMITING SYNDROME	0.000541419	0.05411260240891637
WIEACKER-WOLFF SYNDROME	0.000541419	0.05411260240891637
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000541419	0.05411260240891637
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.000541419	0.05411260240891637
PELIZAEUS-MERZBACHER DISEASE	0.000541419	0.05411260240891637
WAISMAN SYNDROME; WSMN	0.000541419	0.05411260240891637
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.05411260240891637
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED 104; MRX104	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED 103	0.000541419	0.05411260240891637
XQ25 DUPLICATION SYNDROME	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.05411260240891637
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.05411260240891637
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000541419	0.05411260240891637
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.000541419	0.05411260240891637
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.05411260240891637
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.000541419	0.05411260240891637
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.000541419	0.05411260240891637
ATKIN-FLAITZ SYNDROME	0.000541419	0.05411260240891637
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.05411260240891637
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED 72	0.000541419	0.05411260240891637
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.05411260240891637
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.05411260240891637
LISSENCEPHALY, X-LINKED, 2	0.000541419	0.05411260240891637
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000541419	0.05411260240891637
MEHMO SYNDROME; MEHMO	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.05411260240891637
RAYNAUD-CLAES SYNDROME; MRXSRC	0.000541419	0.05411260240891637
ADRENOLEUKODYSTROPHY	0.000541419	0.05411260240891637
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.000541419	0.05411260240891637
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000541419	0.05411260240891637
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.000541419	0.05411260240891637
IMMUNODEFICIENCY 47	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.000541419	0.05411260240891637
MEND SYNDROME; MEND	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.05411260240891637
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED 98; MRX98	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.000541419	0.05411260240891637
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.000541419	0.05411260240891637
CLARK-BARAITSER SYNDROME	0.000541419	0.05411260240891637
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.05411260240891637
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000541419	0.05411260240891637
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED 88	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED 90	0.000541419	0.05411260240891637
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.05411260240891637
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.05411260240891637
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.05411260240891637
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.000541419	0.05411260240891637
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.05411260240891637
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.05411260240891637
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000541419	0.05411260240891637
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000541419	0.05411260240891637
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000541419	0.05411260240891637
GLUTAMINE DEFICIENCY, CONGENITAL	0.000541419	0.05411260240891637
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.05411260240891637
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000541419	0.05411260240891637
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.000541419	0.05411260240891637
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.05411260240891637
CHROMOSOME 10Q26 DELETION SYNDROME	0.000541419	0.05411260240891637
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.05411260240891637
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.000541419	0.05411260240891637
SCHINDLER DISEASE, TYPE I	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.000541419	0.05411260240891637
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000541419	0.05411260240891637
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000541419	0.05411260240891637
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.05411260240891637
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000541419	0.05411260240891637
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.000541419	0.05411260240891637
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.000541419	0.05411260240891637
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.000541419	0.05411260240891637
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.05411260240891637
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.000541419	0.05411260240891637
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.05411260240891637
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000541419	0.05411260240891637
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.000541419	0.05411260240891637
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.05411260240891637
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.000541419	0.05411260240891637
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000541419	0.05411260240891637
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000541419	0.05411260240891637
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000541419	0.05411260240891637
LISSENCEPHALY 3; LIS3	0.000541419	0.05411260240891637
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.000541419	0.05411260240891637
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.05411260240891637
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.000541419	0.05411260240891637
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000541419	0.05411260240891637
POTOCKI-LUPSKI SYNDROME	0.000541419	0.05411260240891637
CORNELIA DE LANGE SYNDROME 3	0.000541419	0.05411260240891637
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000541419	0.05411260240891637
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.05411260240891637
CHROMOSOME 16P13.3 DELETION SYNDROME	0.000541419	0.05411260240891637
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.000541419	0.05411260240891637
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000541419	0.05411260240891637
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.000541419	0.05411260240891637
KOOLEN-DE VRIES SYNDROME; KDVS	0.000541419	0.05411260240891637
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.000541419	0.05411260240891637
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.05411260240891637
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.000541419	0.05411260240891637
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.000541419	0.05411260240891637
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.05411260240891637
KLEEFSTRA SYNDROME	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.000541419	0.05411260240891637
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000541419	0.05411260240891637
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.05411260240891637
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000541419	0.05411260240891637
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000541419	0.05411260240891637
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.05411260240891637
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.000541419	0.05411260240891637
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000541419	0.05411260240891637
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000541419	0.05411260240891637
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000541419	0.05411260240891637
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000541419	0.05411260240891637
MUENKE SYNDROME	0.000541419	0.05411260240891637
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.05411260240891637
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000541419	0.05411260240891637
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.05411260240891637
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000541419	0.05411260240891637
GRACILE BONE DYSPLASIA; GCLEB	0.000541419	0.05411260240891637
PIERPONT SYNDROME	0.000541419	0.05411260240891637
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.05411260240891637
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.05411260240891637
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.05411260240891637
CHROMOSOME 18Q DELETION SYNDROME	0.000541419	0.05411260240891637
PALLISTER-KILLIAN SYNDROME	0.000541419	0.05411260240891637
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.05411260240891637
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.000541419	0.05411260240891637
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000541419	0.05411260240891637
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.000541419	0.05411260240891637
SALLA DISEASE	0.000541419	0.05411260240891637
CRANIOSYNOSTOSIS 2	0.000541419	0.05411260240891637
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.000541419	0.05411260240891637
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000541419	0.05411260240891637
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.05411260240891637
ALZHEIMER DISEASE 3; AD	0.000541419	0.05411260240891637
NIEMANN-PICK DISEASE, TYPE C2	0.000541419	0.05411260240891637
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.05411260240891637
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000541419	0.05411260240891637
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.05411260240891637
LISSENCEPHALY 1; LIS1	0.000541419	0.05411260240891637
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000541419	0.05411260240891637
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.05411260240891637
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.05411260240891637
LATHOSTEROLOSIS	0.000541419	0.05411260240891637
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.05411260240891637
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000541419	0.05411260240891637
KUFOR-RAKEB SYNDROME	0.000541419	0.05411260240891637
PHACE ASSOCIATION	0.000541419	0.05411260240891637
PHELAN-MCDERMID SYNDROME	0.000541419	0.05411260240891637
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.000541419	0.05411260240891637
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.05411260240891637
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.05411260240891637
BOHRING-OPITZ SYNDROME	0.000541419	0.05411260240891637
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.05411260240891637
ZUNICH NEUROECTODERMAL SYNDROME	0.000541419	0.05411260240891637
XYLOSIDASE DEFICIENCY	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.000541419	0.05411260240891637
C SYNDROME	0.000541419	0.05411260240891637
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.05411260240891637
BANGSTAD SYNDROME	0.000541419	0.05411260240891637
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.000541419	0.05411260240891637
SECKEL SYNDROME 1; SCKL1	0.000541419	0.05411260240891637
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.000541419	0.05411260240891637
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.000541419	0.05411260240891637
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000541419	0.05411260240891637
AUTISM	0.000541419	0.05411260240891637
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.000541419	0.05411260240891637
ASPARTYLGLUCOSAMINURIA; AGU	0.000541419	0.05411260240891637
ARGININOSUCCINIC ACIDURIA	0.000541419	0.05411260240891637
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000541419	0.05411260240891637
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.05411260240891637
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.05411260240891637
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.05411260240891637
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.05411260240891637
ALEXANDER DISEASE	0.000541419	0.05411260240891637
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.05411260240891637
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.000541419	0.05411260240891637
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000541419	0.05411260240891637
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.05411260240891637
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.05411260240891637
ACROCALLOSAL SYNDROME; ACLS	0.000541419	0.05411260240891637
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.000541419	0.05411260240891637
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.05411260240891637
WEAVER SYNDROME	0.000541419	0.05411260240891637
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.05411260240891637
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.000541419	0.05411260240891637
DIAMINOPENTANURIA	0.000541419	0.05411260240891637
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.05411260240891637
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000541419	0.05411260240891637
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.000541419	0.05411260240891637
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000541419	0.05411260240891637
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000541419	0.05411260240891637
CROME SYNDROME	0.000541419	0.05411260240891637
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.05411260240891637
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.05411260240891637
TEMTAMY SYNDROME; TEMTYS	0.000541419	0.05411260240891637
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.05411260240891637
COHEN SYNDROME	0.000541419	0.05411260240891637
COCKAYNE SYNDROME A; CSA	0.000541419	0.05411260240891637
COACH SYNDROME	0.000541419	0.05411260240891637
CITRULLINEMIA, CLASSIC	0.000541419	0.05411260240891637
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.05411260240891637
GRISCELLI SYNDROME, TYPE 1	0.000541419	0.05411260240891637
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000541419	0.05411260240891637
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.000541419	0.05411260240891637
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.000541419	0.05411260240891637
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.05411260240891637
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.05411260240891637
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.05411260240891637
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000541419	0.05411260240891637
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.05411260240891637
DIGEORGE SYNDROME; DGS	0.000541419	0.05411260240891637
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.05411260240891637
ZIMMERMANN-LABAND SYNDROME 1	0.000541419	0.05411260240891637
EPILEPSY, READING	0.000541419	0.05411260240891637
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.05411260240891637
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.05411260240891637
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.05411260240891637
DARIER-WHITE DISEASE; DAR	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.000541419	0.05411260240891637
CROUZON SYNDROME	0.000541419	0.05411260240891637
CORNELIA DE LANGE SYNDROME 1	0.000541419	0.05411260240891637
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.05411260240891637
PAPILLORENAL SYNDROME	0.000541419	0.05411260240891637
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.05411260240891637
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000541419	0.05411260240891637
BRANCHIOOCULOFACIAL SYNDROME	0.000541419	0.05411260240891637
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.05411260240891637
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.05411260240891637
ADENYLOSUCCINASE DEFICIENCY	0.000541419	0.05411260240891637
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.05411260240891637
ADAMS-OLIVER SYNDROME 1; AOS1	0.000541419	0.05411260240891637
15Q13.3 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.05411260240891637
2Q33.1 DELETION SYNDROME	0.000541419	0.05411260240891637
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.05411260240891637
POTOCKI-SHAFFER SYNDROME	0.000541419	0.05411260240891637
1P36 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
COFFIN-SIRIS SYNDROME 1; CSS1	0.000541419	0.05411260240891637
FLYNN-AIRD SYNDROME	0.000541419	0.05411260240891637
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.05411260240891637
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.05411260240891637
STURGE-WEBER SYNDROME	0.000541419	0.05411260240891637
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.05411260240891637
SNEDDON SYNDROME	0.000541419	0.05411260240891637
RECOMBINANT CHROMOSOME 8 SYNDROME	0.000541419	0.05411260240891637
PRADER-WILLI SYNDROME; PWS	0.000541419	0.05411260240891637
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.05411260240891637
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.05411260240891637
PARIETAL FORAMINA	0.000541419	0.05411260240891637
OCULODENTODIGITAL DYSPLASIA; ODDD	0.000541419	0.05411260240891637
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.05411260240891637
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.05411260240891637
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.05411260240891637
MYHRE SYNDROME	0.000541419	0.05411260240891637
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.05411260240891637
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.05411260240891637
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.000541419	0.05411260240891637
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.05411260240891637
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.05411260240891637
KBG SYNDROME	0.000541419	0.05411260240891637
KABUKI SYNDROME 1	0.000541419	0.05411260240891637
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.05411260240891637
HUNTINGTON DISEASE; HD	0.000541419	0.05411260240891637
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000541419	0.05411260240891637
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.05411260240891637
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.05411260240891637
DYSOSTEOSCLEROSIS	0.000541419	0.05411260240891637
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000541419	0.05411260240891637
METHYLMALONIC ACIDURIA, CBLA TYPE	0.000541419	0.05411260240891637
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.05411260240891637
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.05411260240891637
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000541419	0.05411260240891637
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.000541419	0.05411260240891637
ELEJALDE DISEASE	0.000541419	0.05411260240891637
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.000541419	0.05411260240891637
NEURAMINIDASE DEFICIENCY	0.000541419	0.05411260240891637
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.05411260240891637
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.05411260240891637
LEIGH SYNDROME; LS	0.000541419	0.05411260240891637
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.05411260240891637
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.05411260240891637
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.05411260240891637
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.000541419	0.05411260240891637
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.05411260240891637
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.000541419	0.05411260240891637
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.05411260240891637
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.05411260240891637
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.05411260240891637
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.000541419	0.05411260240891637
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.000541419	0.05411260240891637
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000541419	0.05411260240891637
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.000541419	0.05411260240891637
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000541419	0.05411260240891637
PEHO SYNDROME; PEHO	0.000541419	0.05411260240891637
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.05411260240891637
PETERS-PLUS SYNDROME; PTRPLS	0.000541419	0.05411260240891637
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.05411260240891637
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000541419	0.05411260240891637
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000541419	0.05411260240891637
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.000541419	0.05411260240891637
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000541419	0.05411260240891637
THYROCEREBRORETINAL SYNDROME	0.000541419	0.05411260240891637
THREONINEMIA	0.000541419	0.05411260240891637
TAY-SACHS DISEASE; TSD	0.000541419	0.05411260240891637
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.05411260240891637
FILIPPI SYNDROME; FLPIS	0.000541419	0.05411260240891637
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.05411260240891637
SULFOCYSTEINURIA	0.000541419	0.05411260240891637
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.05411260240891637
PHENYLKETONURIA	0.000541419	0.05411260240891637
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000541419	0.05411260240891637
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.05411260240891637
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.05411260240891637
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000541419	0.05411260240891637
RAMON SYNDROME	0.000541419	0.05411260240891637
PYRUVATE CARBOXYLASE DEFICIENCY	0.000541419	0.05411260240891637
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.05411260240891637
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.05411260240891637
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000541419	0.05411260240891637
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000541419	0.05411260240891637
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.000541419	0.05411260240891637
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.05411260240891637
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000541419	0.05411260240891637
EPILEPSY-TELANGIECTASIA	0.000541419	0.05411260240891637
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.05411260240891637
HYPERPROLINEMIA, TYPE II	0.000541419	0.05411260240891637
HYPERPROLINEMIA, TYPE I	0.000541419	0.05411260240891637
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.05411260240891637
HYPERLYSINEMIA, TYPE I	0.000541419	0.05411260240891637
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.05411260240891637
HYPER-BETA-ALANINEMIA	0.000541419	0.05411260240891637
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.05411260240891637
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.000541419	0.05411260240891637
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000541419	0.05411260240891637
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.000541419	0.05411260240891637
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.000541419	0.05411260240891637
HARTNUP DISORDER	0.000541419	0.05411260240891637
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.000541419	0.05411260240891637
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000541419	0.05411260240891637
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.05411260240891637
BERNARD-SOULIER SYNDROME	0.000541419	0.05411260240891637
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.05411260240891637
GAUCHER DISEASE, TYPE II	0.000541419	0.05411260240891637
GAPO SYNDROME; GAPOS	0.000541419	0.05411260240891637
FRYNS SYNDROME; FRNS	0.000541419	0.05411260240891637
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.05411260240891637
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.05411260240891637
FOUNTAIN SYNDROME	0.000541419	0.05411260240891637
FOLATE MALABSORPTION, HEREDITARY	0.000541419	0.05411260240891637
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.05411260240891637
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.05411260240891637
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.05411260240891637
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.05411260240891637
MACDERMOT-WINTER SYNDROME	0.000541419	0.05411260240891637
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.000541419	0.05411260240891637
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.05411260240891637
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000541419	0.05411260240891637
OHDO SYNDROME	0.000541419	0.05411260240891637
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.05411260240891637
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000541419	0.05411260240891637
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.000541419	0.05411260240891637
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.05411260240891637
MARDEN-WALKER SYNDROME	0.000541419	0.05411260240891637
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.05411260240891637
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.05411260240891637
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.05411260240891637
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.000541419	0.05411260240891637
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.000541419	0.05411260240891637
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.000541419	0.05411260240891637
LANDAU-KLEFFNER SYNDROME	0.000541419	0.05411260240891637
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.000541419	0.05411260240891637
KRABBE DISEASE	0.000541419	0.05411260240891637
KIFAFA SEIZURE DISORDER	0.000541419	0.05411260240891637
KEUTEL SYNDROME; KTLS	0.000541419	0.05411260240891637
KETOADIPICACIDURIA	0.000541419	0.05411260240891637
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.05411260240891637
BARAITSER-WINTER SYNDROME 1; BRWS1	0.000541419	0.05411260240891637
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.05411260240891637
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000541419	0.05411260240891637
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION	0.000541419	0.05411260240891637
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.000541419	0.05411260240891637
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.000541419	0.05411260240891637
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000541419	0.05411260240891637
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.000541419	0.05411260240891637
AL KAISSI SYNDROME; ALKAS	0.000541419	0.05411260240891637
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000541419	0.05411260240891637
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000541419	0.05411260240891637
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.000541419	0.05411260240891637
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.000541419	0.05411260240891637
JOUBERT SYNDROME 30; JBTS30	0.000541419	0.05411260240891637
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.000541419	0.05411260240891637
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000541419	0.05411260240891637
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.000541419	0.05411260240891637
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000541419	0.05411260240891637
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.000541419	0.05411260240891637
KLEEFSTRA SYNDROME 2; KLEFS2	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000541419	0.05411260240891637
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.05411260240891637
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000541419	0.05411260240891637
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.000541419	0.05411260240891637
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.000541419	0.05411260240891637
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.05411260240891637
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.05411260240891637
CHROMOSOME 1P35 DELETION SYNDROME	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000541419	0.05411260240891637
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.05411260240891637
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.000541419	0.05411260240891637
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.000541419	0.05411260240891637
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000541419	0.05411260240891637
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.000541419	0.05411260240891637
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.05411260240891637
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.000541419	0.05411260240891637
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000541419	0.05411260240891637
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.05411260240891637
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.000541419	0.05411260240891637
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.000541419	0.05411260240891637
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000541419	0.05411260240891637
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.000541419	0.05411260240891637
MIRAGE SYNDROME; MIRAGE	0.000541419	0.05411260240891637
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.05411260240891637
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.05411260240891637
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000541419	0.05411260240891637
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000541419	0.05411260240891637
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000541419	0.05411260240891637
COFFIN-SIRIS SYNDROME 5	0.000541419	0.05411260240891637
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.05411260240891637
HEART AND BRAIN MALFORMATION SYNDROME	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000541419	0.05411260240891637
ZTTK SYNDROME; ZTTKS	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000541419	0.05411260240891637
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.000541419	0.05411260240891637
LISSENCEPHALY 8; LIS8	0.000541419	0.05411260240891637
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000541419	0.05411260240891637
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.000541419	0.05411260240891637
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.05411260240891637
PSEUDO-TORCH SYNDROME 2	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.000541419	0.05411260240891637
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.000541419	0.05411260240891637
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.000541419	0.05411260240891637
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.000541419	0.05411260240891637
IMMUNODEFICIENCY 49; IMD49	0.000541419	0.05411260240891637
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000541419	0.05411260240891637
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.000541419	0.05411260240891637
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.05411260240891637
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.000541419	0.05411260240891637
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000541419	0.05411260240891637
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000541419	0.05411260240891637
SHASHI-PENA SYNDROME; SHAPNS	0.000541419	0.05411260240891637
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.000541419	0.05411260240891637
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000541419	0.05411260240891637
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000541419	0.05411260240891637
JABERI-ELAHI SYNDROME; JABELS	0.000541419	0.05411260240891637
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.000541419	0.05411260240891637
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
ROMANO-WARD SYNDROME	0.000541419	0.05411260240891637
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.05411260240891637
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.05411260240891637
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.05411260240891637
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.05411260240891637
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.05411260240891637
2Q37 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.05411260240891637
ATAXIA-TELANGIECTASIA	0.000541419	0.05411260240891637
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.000541419	0.05411260240891637
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.000541419	0.05411260240891637
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.000541419	0.05411260240891637
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000541419	0.05411260240891637
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.000541419	0.05411260240891637
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.000541419	0.05411260240891637
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.000541419	0.05411260240891637
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.000541419	0.05411260240891637
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000541419	0.05411260240891637
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.05411260240891637
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.05411260240891637
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000541419	0.05411260240891637
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.05411260240891637
CADASIL	0.000541419	0.05411260240891637
BETA-KETOTHIOLASE DEFICIENCY	0.000541419	0.05411260240891637
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.05411260240891637
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.000541419	0.05411260240891637
SYMMETRICAL THALAMIC CALCIFICATIONS	0.000541419	0.05411260240891637
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.05411260240891637
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.000541419	0.05411260240891637
BRANCHIOSKELETOGENITAL SYNDROME	0.000541419	0.05411260240891637
BOWEN-CONRADI SYNDROME	0.000541419	0.05411260240891637
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.000541419	0.05411260240891637
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.000541419	0.05411260240891637
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.05411260240891637
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.05411260240891637
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.000541419	0.05411260240891637
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.05411260240891637
BETA-MANNOSIDOSIS	0.000541419	0.05411260240891637
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.05411260240891637
BEHÇET DISEASE	0.000541419	0.05411260240891637
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.000541419	0.05411260240891637
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.000541419	0.05411260240891637
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.05411260240891637
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.05411260240891637
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.05411260240891637
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.000541419	0.05411260240891637
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.05411260240891637
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.000541419	0.05411260240891637
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000541419	0.05411260240891637
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000541419	0.05411260240891637
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.000541419	0.05411260240891637
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.05411260240891637
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000541419	0.05411260240891637
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.05411260240891637
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000541419	0.05411260240891637
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.000541419	0.05411260240891637
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.000541419	0.05411260240891637
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000541419	0.05411260240891637
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000541419	0.05411260240891637
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.000541419	0.05411260240891637
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.000541419	0.05411260240891637
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.000541419	0.05411260240891637
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.000541419	0.05411260240891637
HYPEREKPLEXIA 4; HKPX4	0.000541419	0.05411260240891637
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.05411260240891637
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.05411260240891637
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.000541419	0.05411260240891637
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000541419	0.05411260240891637
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000541419	0.05411260240891637
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.05411260240891637
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.000541419	0.05411260240891637
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.05411260240891637
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.000541419	0.05411260240891637
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.000541419	0.05411260240891637
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000541419	0.05411260240891637
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000541419	0.05411260240891637
SOTOS SYNDROME	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000541419	0.05411260240891637
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000541419	0.05411260240891637
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.000541419	0.05411260240891637
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.05411260240891637
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.000541419	0.05411260240891637
PONTINE TEGMENTAL CAP DYSPLASIA	0.000541419	0.05411260240891637
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.000541419	0.05411260240891637
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.000541419	0.05411260240891637
COFFIN-SIRIS SYNDROME 4; CSS4	0.000541419	0.05411260240891637
COFFIN-SIRIS SYNDROME 3; CSS3	0.000541419	0.05411260240891637
COFFIN-SIRIS SYNDROME 2; CSS2	0.000541419	0.05411260240891637
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.000541419	0.05411260240891637
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000541419	0.05411260240891637
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000541419	0.05411260240891637
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.05411260240891637
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000541419	0.05411260240891637
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.05411260240891637
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000541419	0.05411260240891637
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.000541419	0.05411260240891637
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000541419	0.05411260240891637
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.05411260240891637
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.000541419	0.05411260240891637
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.000541419	0.05411260240891637
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000541419	0.05411260240891637
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.05411260240891637
ADAMS-OLIVER SYNDROME 2; AOS2	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000541419	0.05411260240891637
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.000541419	0.05411260240891637
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.000541419	0.05411260240891637
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000541419	0.05411260240891637
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.000541419	0.05411260240891637
COWDEN SYNDROME 6; CWS6	0.000541419	0.05411260240891637
COWDEN SYNDROME 5; CWS5	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.000541419	0.05411260240891637
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.000541419	0.05411260240891637
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.000541419	0.05411260240891637
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.000541419	0.05411260240891637
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.000541419	0.05411260240891637
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000541419	0.05411260240891637
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.000541419	0.05411260240891637
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000541419	0.05411260240891637
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.000541419	0.05411260240891637
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000541419	0.05411260240891637
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.000541419	0.05411260240891637
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000541419	0.05411260240891637
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000541419	0.05411260240891637
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000541419	0.05411260240891637
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.000541419	0.05411260240891637
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.000541419	0.05411260240891637
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.05411260240891637
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000541419	0.05411260240891637
SECKEL SYNDROME 7; SCKL7	0.000541419	0.05411260240891637
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000541419	0.05411260240891637
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000541419	0.05411260240891637
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000541419	0.05411260240891637
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.05411260240891637
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.000541419	0.05411260240891637
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.05411260240891637
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.000541419	0.05411260240891637
GABA-TRANSAMINASE DEFICIENCY	0.000541419	0.05411260240891637
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.05411260240891637
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.05411260240891637
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.05411260240891637
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000541419	0.05411260240891637
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.000541419	0.05411260240891637
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000541419	0.05411260240891637
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000541419	0.05411260240891637
EPISODIC ATAXIA, TYPE 6	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.000541419	0.05411260240891637
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000541419	0.05411260240891637
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.000541419	0.05411260240891637
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.000541419	0.05411260240891637
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000541419	0.05411260240891637
GLASS SYNDROME	0.000541419	0.05411260240891637
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000541419	0.05411260240891637
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.000541419	0.05411260240891637
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.05411260240891637
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.000541419	0.05411260240891637
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.000541419	0.05411260240891637
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000541419	0.05411260240891637
WITTEVEEN-KOLK SYNDROME	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.05411260240891637
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.05411260240891637
PERRAULT SYNDROME 3	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.000541419	0.05411260240891637
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.000541419	0.05411260240891637
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.000541419	0.05411260240891637
N-ACETYLASPARTATE DEFICIENCY; NACED	0.000541419	0.05411260240891637
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000541419	0.05411260240891637
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000541419	0.05411260240891637
LISSENCEPHALY 4	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.000541419	0.05411260240891637
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.05411260240891637
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.05411260240891637
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.000541419	0.05411260240891637
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000541419	0.05411260240891637
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.000541419	0.05411260240891637
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.05411260240891637
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000541419	0.05411260240891637
NOONAN SYNDROME 7; NS7	0.000541419	0.05411260240891637
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.000541419	0.05411260240891637
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.05411260240891637
LISSENCEPHALY 5; LIS5	0.000541419	0.05411260240891637
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000541419	0.05411260240891637
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000541419	0.05411260240891637
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.000541419	0.05411260240891637
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.000541419	0.05411260240891637
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.000541419	0.05411260240891637
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.05411260240891637
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.000541419	0.05411260240891637
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.000541419	0.05411260240891637
TENORIO SYNDROME; TNORS	0.000541419	0.05411260240891637
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.000541419	0.05411260240891637
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000541419	0.05411260240891637
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000541419	0.05411260240891637
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.05411260240891637
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000541419	0.05411260240891637
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.000541419	0.05411260240891637
CATEL-MANZKE SYNDROME; CATMANS	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.000541419	0.05411260240891637
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000541419	0.05411260240891637
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.05411260240891637
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000541419	0.05411260240891637
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.000541419	0.05411260240891637
CHROMOSOME 16P13.2 DELETION SYNDROME	0.000541419	0.05411260240891637
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000541419	0.05411260240891637
LUSCAN-LUMISH SYNDROME; LLS	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000541419	0.05411260240891637
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.000541419	0.05411260240891637
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.000541419	0.05411260240891637
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.000541419	0.05411260240891637
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.05411260240891637
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.000541419	0.05411260240891637
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.000541419	0.05411260240891637
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.000541419	0.05411260240891637
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.000541419	0.05411260240891637
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000541419	0.05411260240891637
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.05411260240891637
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000541419	0.05411260240891637
SMITH-KINGSMORE SYNDROME; SKS	0.000541419	0.05411260240891637
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.05411260240891637
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.000541419	0.05411260240891637
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.05411260240891637
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.05411260240891637
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.05411260240891637
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000541419	0.05411260240891637
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.000541419	0.05411260240891637
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.05411260240891637
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.05411260240891637
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.000541419	0.05411260240891637
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.000541419	0.05411260240891637
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.000541419	0.05411260240891637
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000541419	0.05411260240891637
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000541419	0.05411260240891637
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.05411260240891637
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.000541419	0.05411260240891637
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.000541419	0.05411260240891637
INFANTILE LIVER FAILURE SYNDROME 1	0.000541419	0.05411260240891637
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000541419	0.05411260240891637
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000541419	0.05411260240891637
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.000541419	0.05411260240891637
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.05411260240891637
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.000541419	0.05411260240891637
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.05411260240891637
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.000541419	0.05411260240891637
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.000541419	0.05411260240891637
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.000541419	0.05411260240891637
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.000541419	0.05411260240891637
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.000541419	0.05411260240891637
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000541419	0.05411260240891637
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.000541419	0.05411260240891637
CHROMOSOME 5Q12 DELETION SYNDROME	0.000541419	0.05411260240891637
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000541419	0.05411260240891637
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.05411260240891637
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.05411260240891637
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000541419	0.05411260240891637
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.05411260240891637
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.05411260240891637
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000541419	0.05411260240891637
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000541419	0.05411260240891637
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.05411260240891637
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.05411260240891637
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.000541419	0.05411260240891637
HELSMOORTEL-VAN DER AA SYNDROME	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000541419	0.05411260240891637
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000541419	0.05411260240891637
AICARDI-GOUTIERES SYNDROME 7	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000541419	0.05411260240891637
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000541419	0.05411260240891637
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000541419	0.05411260240891637
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000541419	0.05411260240891637
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.05411260240891637
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.05411260240891637
